DoD Prostate Cancer, Health Equity Research and Outcomes Improvement Consortium Award — Defense Health Agency Contracting Activity - DHACA funding opportunity
Defense Health Agency Contracting Activity - DHACA · Federal agency

DoD Prostate Cancer, Health Equity Research and Outcomes Improvement Consortium Award

The FY21 PCRP Health Equity Research and Outcomes Improvement Consortium (HEROIC) Award supports a synergistic, multi-institutional collaboration incorporating innovative and translational approaches that have the potent...

81
match
Deadline 1782 days ago Location Alabama Type grant Level Federal Closed posted Apr 8, 2021
✦ AI Summary
  • Who can apply: Federal-level applicants (see eligibility for details).
  • Funding amount: total funding pool ~$12,960,000.
  • Next deadline: August 4, 2021.
  • Issued by: Defense Health Agency Contracting Activity - DHACA.
How was this generated?

The “key facts” mode pulls structured fields directly from the official source posting (amount, deadline, eligibility tags). The AI mode adds a short plain-English narrative on top, generated from the same source. Always verify with the agency before applying.

AI-generated. Always verify with the official source.

Deadline
1782 days ago
Aug 4, 2021
Total pool
$13.0M

About this opportunity

The FY21 PCRP Health Equity Research and Outcomes Improvement Consortium (HEROIC) Award supports a synergistic, multi-institutional collaboration incorporating innovative and translational approaches that have the potential to make a major impact on specific FY21 PCRP Overarching Challenges. Therefore, all applications are required to address one or both of the following FY21 PCRP Overarching Challenges:• Improve quality of life to enhance outcomes and overall health and wellness for those impacted by prostate cancerApplications should aim to understand the impact of prostate cancer on quality of life for the cancer survivor, their their community with the goal of improving and enhancing quality of life and overall health and wellness. Studies should consider both short- and long-term quality of life outcomes. Areas of particular interest include:o The mental and emotional health of patients and their families/caregiverso Impact of quality of life considerations on decision-making after diagnosis and/or treatmento Identification of vulnerable groups of men and their families at great risk of quality of life detrimentso Translation of factors or interventions that improve quality of life outcomes and overall health and wellness• Advance Health Equity and Reduce Disparities in Prostate CancerApplications must be directly relevant to the better understanding and/or reduction of inequities and disparities that impact a person, their family, or their caregiver's ability to survive prostate cancer.Inequities may arise from socioeconomic status, race or and/or gender identification, access to care (in rural or urban settings), or other factors.Health inequities may include emotional health differences, as well as social and financial differences experienced primarily in high-risk or underserved prostate cancer patients.High-risk populations include, but are not limited to, people of African descent (including Caribbean), genetically predisposed populations, Service Members, and Veterans.Underserved populations include, but are not limited to, men with limited access to clinical care and resources (in rural or urban settings), and sexual and/or gender minorities.Each application must outline and identify all key members of the consortium, which must include four to six Research Teams total; one Research Team will be led by a Consortium Director, and the remaining three to five Research Teams will be led by Research Team Principal Investigators (PIs). A minimum of three institutions must be represented. The consortium must include leading scientists and/or clinicians who have specific expertise related to prostate cancer, health disparities, and/or survivorship research or other areas of expertise related to addressing the overarching theme of the proposal. All consortia must include at least one prostate cancer consumer advocate that has an active role in every aspect of the proposed consortium’s work.Consortia funding will be offered in two phases. Phase 1 of the HEROIC Award will enable the consortium to lay the groundwork for the research effort, including the conduct of preliminary research projects to demonstrate proof of concept of the proposed central hypothesis. Phase 2 of the HEROIC Award will enable the execution of the full research effort, including multiple, parallel projects supported by the preliminary data generated in phase 1, which approach the research problem from a variety of perspectives. Phase 1 awardees will be eligible to compete for phase 2 funding in FY23 pending availability of funds.

Funding agency

Tags

Want help applying?

Our specialists will check your eligibility, prepare the application, and walk you through every step — for free. Create a free account →

Who can apply

Eligibility details aren't on file yet — check the agency source link in the Documents tab for the latest rules.

Geographic eligibility

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado
  • Connecticut
  • Delaware
  • Florida
  • Georgia
  • Hawaii
  • Idaho
  • Illinois
  • Indiana
  • Iowa
  • Kansas
  • Kentucky
  • Louisiana
  • Maine
  • Maryland
  • Massachusetts
  • Michigan
  • Minnesota
  • Mississippi
  • Missouri
  • Montana
  • Nebraska
  • Nevada
  • New Hampshire
  • New Jersey
  • New Mexico
  • New York
  • North Carolina
  • North Dakota
  • Ohio
  • Oklahoma
  • Oregon
  • Pennsylvania
  • Rhode Island
  • South Carolina
  • South Dakota
  • Tennessee
  • Texas
  • Utah
  • Vermont
  • Virginia
  • Washington
  • West Virginia
  • Wisconsin
  • Wyoming
  • District of Columbia

How to apply

We don't have application instructions on file yet — head straight to the official source.

Apply on agency site
Tip from our team:

Read the agency's eligibility checklist before you start — it's almost always shorter than the full NOFO and will tell you in 90 seconds whether to keep going.

Need help getting in touch with the right agency contact?

Create a free account and our specialists will guide you through the application end-to-end.

Source documents

View on agency site
Canonical NOFO, application packet, and forms
No supplemental documents yet.

Direct downloads (NOFO PDFs, application forms, FAQs) will appear here once our team attaches them. For now, the agency site has the canonical packet.

Citation details

Source systemgrants.gov
Source ID332742
PostedApr 8, 2021

Frequently asked questions

No FAQs yet.

Have a question about this fund? Sign in to open a ticket about this fund.